SG Americas Securities
TYRA icon

SG Americas Securities’s Tyra Biosciences TYRA Stock Holding History

SG Americas Securities’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Buy
+7,215
New +$234K ﹤0.01% 2499
2025
Q4 		– Sell
-9,542
Closed -$133K – 3777
2025
Q3 		$133K Buy
+9,542
New +$109K ﹤0.01% 2964
2025
Q2 		– Sell
-15,120
Closed -$141K – 3610
2025
Q1 		$141K Buy
15,120
+5,449
+56% +$70.5K ﹤0.01% 2796
2024
Q4 		$134K Sell
9,671
-3,540
-27% -$64.2K ﹤0.01% 2507
2024
Q3 		$311K Buy
+13,211
New +$277K ﹤0.01% 2121

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

SG Americas Securities's TYRA Position: Q1 2026 in Review

SG Americas Securities opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 7,215 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #2499 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in TYRA as recently as Q3 2025.

SG Americas Securities first reported a position in TYRA in Q3 2024 and has held it in 5 quarters since. The position peaked at $311K in Q3 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • SG Americas Securities held 7,215 shares of Tyra Biosciences worth $276K as of Q1 2026.
  • Tyra Biosciences was a new SG Americas Securities position in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2499 holding.
  • SG Americas Securities first reported a position in Tyra Biosciences in Q3 2024 and has held it in 5 quarters since.
  • SG Americas Securities's Tyra Biosciences position peaked at $311K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.